Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Oral HRS-5965 in Adult Paroxysmal Nocturnal Hemoglobinuria (PNH) Patients Who Are Naive to Complement Inhibitor Therapy [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial update evaluating the efficacy and safety of oral HRS-5965 in adults with paroxysmal nocturnal hemoglobinuria who have not received com…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Paroxysmal Nocturnal Hemoglobinuria

Drugs mentioned

• HRS-5965

Snippet

Sponsor: Chengdu Suncadia Medicine Co., Ltd. | Conditions: Paroxysmal Nocturnal Hemoglobinuria | Phase 3 | Status: COMPLETED